Recurrent chronic pyoderma with cellular immunodeficiency. Successful therapy by levamisole

Area of Science:

• Immunology
• Dermatology
• Pharmacology

Background:

• A 21-year-old male presented with a 3-year history of widespread, recurrent pyoderma.
• The condition was resistant to multiple courses of antimicrobial therapy.
• Underlying cellular immunodeficiency involving macrophages and T lymphocytes was identified.

Observation:

• Systemic treatment with levamisole was initiated.
• Clinical observation documented complete resolution of all pyoderma lesions after 6 weeks.
• Immunological parameters were re-evaluated during the treatment period.

Findings:

• Levamisole therapy led to complete clearance of pyoderma lesions.
• Previously ineffective antibiotic treatments had failed to achieve remission.
• Re-examination revealed normalization of immunological parameters, indicating restored immune function.

Implications:

• Levamisole demonstrates significant therapeutic potential for antibiotic-resistant pyoderma.
• The drug may correct underlying cellular immune dysfunctions associated with such conditions.
• This case highlights the importance of assessing immune status in refractory skin infections.